LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics


LeMaitre Vascular, Inc. (LMAT): $44.64

-1.52 (-3.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LMAT POWR Grades

  • Quality is the dimension where LMAT ranks best; there it ranks ahead of 90.58% of US stocks.
  • LMAT's strongest trending metric is Quality; it's been moving up over the last 178 days.
  • LMAT ranks lowest in Momentum; there it ranks in the 10th percentile.

LMAT Stock Summary

  • LMAT's current price/earnings ratio is 48.16, which is higher than 88.04% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for LMAT is currently 38.71, higher than 87.81% of US stocks with positive operating cash flow.
  • LMAT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 11.28% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to LEMAITRE VASCULAR INC are GMED, CSPI, SHYF, MMSI, and LNN.
  • LMAT's SEC filings can be seen here. And to visit LEMAITRE VASCULAR INC's official web site, go to www.lemaitre.com.

LMAT Valuation Summary

  • In comparison to the median Healthcare stock, LMAT's price/sales ratio is 215% higher, now standing at 6.3.
  • Over the past 196 months, LMAT's price/sales ratio has gone up 3.4.

Below are key valuation metrics over time for LMAT.

Stock Date P/S P/B P/E EV/EBIT
LMAT 2022-11-25 6.3 3.9 47.9 36.1
LMAT 2022-11-23 6.4 3.9 48.2 36.3
LMAT 2022-11-22 6.3 3.9 47.8 36.0
LMAT 2022-11-21 6.2 3.8 47.1 35.5
LMAT 2022-11-18 6.2 3.8 47.2 35.6
LMAT 2022-11-17 6.2 3.8 46.9 35.3

LMAT Growth Metrics

    Its 3 year revenue growth rate is now at 46.32%.
  • The 5 year net income to common stockholders growth rate now stands at 66.15%.
  • The 2 year net cashflow from operations growth rate now stands at 116.46%.
Over the past 33 months, LMAT's revenue has gone up $42,968,000.

The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 160.2 26.357 21.184
2022-06-30 159.54 33.09 22.232
2022-03-31 158.102 33.739 27.016
2021-12-31 154.424 35.102 26.907
2021-09-30 152.469 44.198 27.765
2021-06-30 150.517 44.235 28.774

LMAT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LMAT has a Quality Grade of B, ranking ahead of 84.43% of graded US stocks.
  • LMAT's asset turnover comes in at 0.589 -- ranking 73rd of 186 Medical Equipment stocks.
  • ISRG, SYK, and KIDS are the stocks whose asset turnover ratios are most correlated with LMAT.

The table below shows LMAT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.589 0.655 0.287
2021-06-30 0.597 0.649 0.299
2021-03-31 0.530 0.653 0.241
2020-12-31 0.542 0.654 0.220
2020-09-30 0.548 0.657 0.196
2020-06-30 0.574 0.677 0.177

LMAT Price Target

For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $66.14 Average Broker Recommendation 1.5 (Moderate Buy)

LMAT Stock Price Chart Interactive Chart >

Price chart for LMAT

LMAT Price/Volume Stats

Current price $44.64 52-week high $56.38
Prev. close $46.16 52-week low $38.32
Day low $44.53 Volume 65,500
Day high $46.32 Avg. volume 107,075
50-day MA $47.72 Dividend yield 1.12%
200-day MA $46.93 Market Cap 982.12M

LeMaitre Vascular, Inc. (LMAT) Company Bio


LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.


LMAT Latest News Stream


Event/Time News Detail
Loading, please wait...

LMAT Latest Social Stream


Loading social stream, please wait...

View Full LMAT Social Stream

Latest LMAT News From Around the Web

Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.

Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

LeMaitre Vascular, Inc. ( NASDAQ:LMAT ), is not the largest company out there, but it saw a double-digit share price...

Yahoo | November 25, 2022

Is This Underfollowed Dividend Stock a Buy?

Rising interest rates and fears of a global recession spooked investors, crushing many growth stocks in 2022. Shares of medical device maker LeMaitre Vascular (NASDAQ: LMAT) are down just 12% so far in 2022. The company was helped by the continued strong demand for medical devices even as the economy started slowing.

Yahoo | November 23, 2022

LeMaitre to Present at Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences. David Roberts, President, will present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 3:10 PM ET. He is also scheduled to present at the Sidoti Small-Cap Virtual Conference on Thursday, December 8, 20

Yahoo | November 22, 2022

LeMaitre Vascular Third Quarter 2022 Earnings: Misses Expectations

LeMaitre Vascular ( NASDAQ:LMAT ) Third Quarter 2022 Results Key Financial Results Revenue: US$39.0m (up 1.7% from 3Q...

Yahoo | November 11, 2022

LeMaitre Vascular (NASDAQ:LMAT) Will Want To Turn Around Its Return Trends

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Yahoo | November 3, 2022

Read More 'LMAT' Stories Here

LMAT Price Returns

1-mo 6.74%
3-mo -9.36%
6-mo -2.46%
1-year -5.61%
3-year 29.57%
5-year 42.71%
YTD -10.18%
2021 25.10%
2020 14.09%
2019 53.77%
2018 -25.13%
2017 26.58%

LMAT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LMAT Dividend History

Continue Researching LMAT

Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:

Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7572 seconds.